204 related articles for article (PubMed ID: 23403560)
1. Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells.
Choi HJ; Kim J; Do KH; Park SH; Moon Y
Infect Immun; 2013 Jun; 81(6):1860-9. PubMed ID: 23403560
[TBL] [Abstract][Full Text] [Related]
2. Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium.
Khan MA; Bouzari S; Ma C; Rosenberger CM; Bergstrom KS; Gibson DL; Steiner TS; Vallance BA
Infect Immun; 2008 Apr; 76(4):1410-22. PubMed ID: 18227166
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cells detect functional type III secretion system of enteropathogenic Escherichia coli through a novel NF-κB signaling pathway.
Litvak Y; Sharon S; Hyams M; Zhang L; Kobi S; Katsowich N; Dishon S; Nussbaum G; Dong N; Shao F; Rosenshine I
PLoS Pathog; 2017 Jul; 13(7):e1006472. PubMed ID: 28671993
[TBL] [Abstract][Full Text] [Related]
4. Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function.
Ruchaud-Sparagano MH; Maresca M; Kenny B
Cell Microbiol; 2007 Aug; 9(8):1909-21. PubMed ID: 17388785
[TBL] [Abstract][Full Text] [Related]
5. Intimate adherence by enteropathogenic Escherichia coli modulates TLR5 localization and proinflammatory host response in intestinal epithelial cells.
Salazar-Gonzalez H; Navarro-Garcia F
Scand J Immunol; 2011 Apr; 73(4):268-83. PubMed ID: 21204905
[TBL] [Abstract][Full Text] [Related]
6. Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination.
Choi HJ; Kim J; Do KH; Park SH; Moon Y
Oncogene; 2013 Oct; 32(41):4960-9. PubMed ID: 23503457
[TBL] [Abstract][Full Text] [Related]
7. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation.
Haller D; Holt L; Kim SC; Schwabe RF; Sartor RB; Jobin C
J Biol Chem; 2003 Jun; 278(26):23851-60. PubMed ID: 12672795
[TBL] [Abstract][Full Text] [Related]
9. Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli.
Savkovic SD; Koutsouris A; Hecht G
Am J Physiol; 1997 Oct; 273(4):C1160-7. PubMed ID: 9357759
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.
Sabharwal H; Cichon C; Ölschläger TA; Sonnenborn U; Schmidt MA
Infect Immun; 2016 Sep; 84(9):2482-92. PubMed ID: 27297392
[TBL] [Abstract][Full Text] [Related]
11. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
[TBL] [Abstract][Full Text] [Related]
12. PKC zeta participates in activation of inflammatory response induced by enteropathogenic E. coli.
Savkovic SD; Koutsouris A; Hecht G
Am J Physiol Cell Physiol; 2003 Sep; 285(3):C512-21. PubMed ID: 12900386
[TBL] [Abstract][Full Text] [Related]
13. Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli.
Hauf N; Chakraborty T
J Immunol; 2003 Feb; 170(4):2074-82. PubMed ID: 12574378
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE.
Vossenkämper A; Marchès O; Fairclough PD; Warnes G; Stagg AJ; Lindsay JO; Evans PC; Luong le A; Croft NM; Naik S; Frankel G; MacDonald TT
J Immunol; 2010 Oct; 185(7):4118-27. PubMed ID: 20833837
[TBL] [Abstract][Full Text] [Related]
15. The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.
Pallett MA; Berger CN; Pearson JS; Hartland EL; Frankel G
Infect Immun; 2014 Nov; 82(11):4878-88. PubMed ID: 25183730
[TBL] [Abstract][Full Text] [Related]
16. BRD4 mediates NF-κB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation.
Tian B; Zhao Y; Sun H; Zhang Y; Yang J; Brasier AR
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1183-L1201. PubMed ID: 27793799
[TBL] [Abstract][Full Text] [Related]
17. Enteropathogenic Escherichia coli dynamically regulates EGFR signaling in intestinal epithelial cells.
Roxas JL; Ryan K; Vedantam G; Viswanathan VK
Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G374-80. PubMed ID: 24904077
[TBL] [Abstract][Full Text] [Related]
18. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8.
Berin MC; Darfeuille-Michaud A; Egan LJ; Miyamoto Y; Kagnoff MF
Cell Microbiol; 2002 Oct; 4(10):635-48. PubMed ID: 12366401
[TBL] [Abstract][Full Text] [Related]
19. Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression.
Neil JR; Schiemann WP
Cancer Res; 2008 Mar; 68(5):1462-70. PubMed ID: 18316610
[TBL] [Abstract][Full Text] [Related]
20. The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors.
Ruchaud-Sparagano MH; Mühlen S; Dean P; Kenny B
PLoS Pathog; 2011 Dec; 7(12):e1002414. PubMed ID: 22144899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
